BIOCRYST PHARMACEUTICALS INC Insider Trading for January 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCRYST PHARMACEUTICALS INC for January 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.88 | 25,000 | 172,015 | 12,641,525 | 12.6 M to 12.6 M (+0.20 %) |
| Jan 29 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.98 | 63,345 | 441,971 | 12,616,525 | 12.6 M to 12.6 M (+0.50 %) |
| Jan 27 2016 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Payment of Exercise | F | 7.29 | 3,850 | 28,067 | 8,605 | 12.5 K to 8.6 K (-30.91 %) |
| Jan 25 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.00 | 3,200 | 22,389 | 12,553,180 | 12.5 M to 12.6 M (+0.03 %) |
| Jan 25 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.29 | 103,600 | 755,368 | 12,549,980 | 12.4 M to 12.5 M (+0.83 %) |
| Jan 22 2016 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 7.55 | 2,599 | 19,622 | 65,689 | 68.3 K to 65.7 K (-3.81 %) |
| Jan 22 2016 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 7.55 | 4,724 | 35,666 | 142,334 | 147.1 K to 142.3 K (-3.21 %) |
| Jan 22 2016 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 7.55 | 5,359 | 40,460 | 88,967 | 94.3 K to 89 K (-5.68 %) |
| Jan 22 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 7.55 | 4,823 | 36,414 | 145,093 | 149.9 K to 145.1 K (-3.22 %) |
| Jan 22 2016 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 7.55 | 10,624 | 80,211 | 665,702 | 676.3 K to 665.7 K (-1.57 %) |
| Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | M | 4.15 | 24,096 | 99,998 | 134,279 | |
| Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | M | 4.15 | 24,096 | 99,998 | 676,326 | 652.2 K to 676.3 K (+3.69 %) |
| Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 1.42 | 12,500 | 17,750 | 87,500 | |
| Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 2,500 | 9,450 | 99,260 | |
| Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 1.42 | 12,500 | 17,750 | 149,916 | 137.4 K to 149.9 K (+9.10 %) |
| Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 2,500 | 9,450 | 137,416 | 134.9 K to 137.4 K (+1.85 %) |
| Jan 20 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.94 | 1,325 | 9,197 | 12,446,380 | 12.4 M to 12.4 M (+0.01 %) |
| Jan 20 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.87 | 51,370 | 352,974 | 12,445,055 | 12.4 M to 12.4 M (+0.41 %) |
| Jan 20 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.12 | 92,200 | 656,750 | 12,393,685 | 12.3 M to 12.4 M (+0.75 %) |
| Jan 20 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.49 | 25,000 | 187,333 | 12,301,485 | 12.3 M to 12.3 M (+0.20 %) |
| Jan 20 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.45 | 175,000 | 1,303,890 | 12,276,485 | 12.1 M to 12.3 M (+1.45 %) |
| Jan 05 2016 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 10.32 | 1,281 | 13,220 | 68,288 | 69.6 K to 68.3 K (-1.84 %) |
| Jan 05 2016 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 10.32 | 1,639 | 16,914 | 147,058 | 148.7 K to 147.1 K (-1.10 %) |
| Jan 05 2016 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 10.32 | 2,081 | 21,476 | 94,326 | 96.4 K to 94.3 K (-2.16 %) |
| Jan 05 2016 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 10.32 | 1,676 | 17,296 | 134,916 | 136.6 K to 134.9 K (-1.23 %) |
| Jan 05 2016 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 10.32 | 8,091 | 83,499 | 652,230 | 660.3 K to 652.2 K (-1.23 %) |